Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Value · Nuveen / TIAA

NQVAX Expense Ratio & Fees

Ticker NQVAX · Since 2002-12-09 · · Holdings as of Jun 30, 2026

Expense ratio
1.09%$109/yr per $10k
5-yr return
+14.1%annualized
1-yr return
+10.9%as of Dec 2025
Net assets
$1.3Ball share classes
Holdings
63

Bottom line

What is NQVAX's expense ratio?

NQVAX's expense ratio is 1.09%, or about $109 a year on every $10,000 invested. That is more expensive than 72% of large value funds we track (median 0.81%). This share class also charges a front-end sales load of up to 5.75%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.

Updated Oct 28, 2026

NQVAX fee table

Net expense ratio1.09%
Gross expense ratio1.17%
Management fee0.68%
12b-1 (distribution) fee0.25%
Other expenses0.24%
Fee waiver / reimbursement-0.08%
Max front-end sales load5.75%
Max deferred sales charge0%

Source: Fund prospectus fee table, filed Oct 28, 2026

What NQVAX costs in dollars

The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:

1 year3 years5 years10 years
NQVAX$680$912$1,169$1,902

Source: Fund prospectus expense example

The long-run cost of fees

On $100,000 growing at 6% a year for 20 years, a 1.09% expense ratio costs roughly $59,900 in lost growth, versus about $45,600 for the median large value fund (0.81%).

Cheapest way to own Nuveen Multi Cap Value Fund

All share classes
TickerClassExpense ratioFront load
NQVRXNuveen Multi Cap Value Fund - Class I0.84%0%
NQVAXNuveen Multi Cap Value Fund - Class A1.09%5.75%
NQVCXNuveen Multi Cap Value Fund - Class C1.84%0%